Namibia:Rains Could Push Up Hepatitis E Cases
[Namibian] THE Namibia Red Cross Society and Unicef yesterday warned members of the public that the rainy season will likely increase the number of hepatitis E virus cases throughout the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 19, 2018 Category: African Health Source Type: news

Women suffer more chemo side effects than men
Study focused on chemo for stomach cancer Related items fromOnMedica Cancer patients using complementary meds die sooner Cancer strategies failed to improve one-year survival FOB associated with rise in all-cause mortality Antivirals cut liver cancer risk after hepatitis C NICE recommends Herceptin for gastric cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 19, 2018 Category: UK Health Source Type: news

Eight Weeks of Antiviral Therapy for Recent HCV Infection Eight Weeks of Antiviral Therapy for Recent HCV Infection
Is an 8-week therapy of paritaprevir/ritonavir/ombitasvir and dasabuvir + ribavirin as effective as the standard 12-week regimen in individuals with recent HCV infection?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

UC researchers recommend universal screening to tackle rise in Hepatitis C
(University of Cincinnati Academic Health Center) Physicians are encountering a growing number of younger patients who are testing positive for hepatitis C virus (HCV) fueled largely by the opioid crisis impacting communities around the country. That increase and more effective and tolerable drug regimens for HCV infection, means one-time universal screening of all adults for HCV is now cost effective and recommended, say physician researchers in the University of Cincinnati (UC) College of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 17, 2018 Category: International Medicine & Public Health Source Type: news

5 Qs on Managing Hepatitis C in the Young
How much do you know about HCV treatment in children and teens? Take this short, 5-question quiz to find out. (Source: ConsultantLive)
Source: ConsultantLive - October 16, 2018 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Hepatitis C Hepatitis C Quiz Source Type: news

Hepatitis A and B Vaccinations
Title: Hepatitis A and B VaccinationsCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/15/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 15, 2018 Category: Nutrition Source Type: news

The Number of Children Without Vaccinations Has Skyrocketed Since 2001, New Reports Find
The number of children who have not received vaccines for preventable diseases has quadrupled since 2001, to an estimated 100,000 individuals, according to a report released by the Centers for Disease Control and Prevention (CDC). Using data from the National Immunization Survey-Child, the CDC report published Thursday found that in 2017, “the percentage of children with no vaccinations by age 2 years increased from 0.9% for children born in 2011 to 1.3% for those born in 2015.” In 2001, that figure was only 0.3%. The survey found that children were least likely to have received vaccinations for hepatitis A and...
Source: TIME: Health - October 12, 2018 Category: Consumer Health News Authors: Wilder Davies Tags: Uncategorized onetime public health Source Type: news

Risk Factors of HCC After HBsAg Seroclearance Risk Factors of HCC After HBsAg Seroclearance
Which factors might increase risk of hepatocellular carcinoma among patients with chronic hepatitis B who have achieved seroclearance of hepatitis B surface antigen?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Most At-Risk Young People Are Not Tested for Hepatitis C Most At-Risk Young People Are Not Tested for Hepatitis C
Young people with opioid use disorder should be screened for hepatitis C, a study of more than 250,000 teens and young adults demonstrated.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 5, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Many Young Drug Abusers Not Tested for Hep C
In a recent federal study, only 36 percent of teens and young adults identified with opioid addiction were tested for hepatitis C, the researchers found, missing a chance to treat the deadly infection. (Source: WebMD Health)
Source: WebMD Health - October 5, 2018 Category: Consumer Health News Source Type: news

Many Young Drug Abusers Not Tested for Hepatitis C, Study Finds
FRIDAY, Oct. 5, 2018 -- Too few teens and young adults with an opioid addiction are tested for hepatitis C, even though they're at high risk for the liver infection, researchers say. In 2016, hepatitis C killed more than 18,000 Americans, making it... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 5, 2018 Category: General Medicine Source Type: news

Many Young Drug Abusers Not Tested for Hepatitis C, Study Finds
Title: Many Young Drug Abusers Not Tested for Hepatitis C, Study FindsCategory: Health NewsCreated: 10/5/2018 12:00:00 AMLast Editorial Review: 10/5/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 5, 2018 Category: Nutrition Source Type: news

New York hepatitis A outbreak traced back to beloved pizza restaurant 
A cook at Doino's Pizzeria Bar & Grille in Cheekatowga, New York, and four patrons who ate at the restaurant between August 20 and September 3 have tested positive for hepatitis A. (Source: the Mail online | Health)
Source: the Mail online | Health - October 4, 2018 Category: Consumer Health News Source Type: news

J & J, Arrowhead partner on gene-silencing drug
Johnson& Johnson ’s Janssen Pharmaceuticals has entered into an agreement with Arrowhead Pharmaceuticals for an exclusive, worldwide license to develop and commercialize a therapy candidate being investigated for the treatment of chronic hepatitis B viral infection. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 4, 2018 Category: Pharmaceuticals Source Type: news

Janssen Announces Exclusive, Worldwide License Agreement with Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection
(Source: Johnson and Johnson)
Source: Johnson and Johnson - October 4, 2018 Category: Pharmaceuticals Source Type: news

J & J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion
Arrowhead Pharmaceuticals Inc said on Thursday Johnson& Johnson would develop and market its gene-silencing Hepatitis B drug and pick up a minor stake in the company in a deal that could be potentially worth more than $3.7 billion. (Source: Reuters: Health)
Source: Reuters: Health - October 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

At-risk teens and young adults overlooked during opioid crisis
(Infectious Diseases Society of America) Teens and young adults who have injected drugs are at risk for contracting hepatitis C, but most aren't tested and therefore don't receive life-saving treatment, according to a national study being presented at IDWeek 2018. The study of more than 250,000 at-risk youth found only one-third of those with diagnosed opioid use disorder (OUD) were tested for hepatitis C. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 4, 2018 Category: Infectious Diseases Source Type: news

HCV Screening in Younger At-Risk Populations
Universal hepatitis C screening for younger adults may be the next essential step in eradicating the infection suggests pediatric ID specialist Claudia Espinosa, MD, MSc.   (Source: ConsultantLive)
Source: ConsultantLive - October 2, 2018 Category: Internal Medicine Authors: Andrew Bowser Tags: Hepatitis C Source Type: news

Tenofovir Beats Entecavir for Preventing Liver Cancer? Tenofovir Beats Entecavir for Preventing Liver Cancer?
An observational study reports that in patients with hepatitis B, tenofovir significantly lowers the risk for liver cancer compared with entecavir.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Genetics of HCV-GT4-infected Patients Treated With OBV/PTV/r Genetics of HCV-GT4-infected Patients Treated With OBV/PTV/r
This study aimed to identify subtypes by geographic region and country.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 2, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

HCV in Young Adults and Children: 3 Studies At-a-Glance
Study summaries highlight increased infection rates in young adults; a spike in HCV in reproductive-aged women; and a potential new treatment for HCV in young children. (Source: ConsultantLive)
Source: ConsultantLive - October 1, 2018 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Hepatitis C Source Type: news

First Human Case of Rat Strain of Hepatitis E
Title: First Human Case of Rat Strain of Hepatitis ECategory: Health NewsCreated: 10/1/2018 12:00:00 AMLast Editorial Review: 10/1/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - October 1, 2018 Category: Nutrition Source Type: news

This Case Shows How You Can Catch Hepatitis E From Rats
Each year approximately 20 million human hepatitis E virus (HEV) infections occur around the world. A 56 year old man is the first known human to get the rat version of HEV. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 29, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

In Hong Kong, Hepatitis E Strain Jumps From Rats to Humans
Researchers stressed the seriousness of even one case of animal-to-human infection in densely populated areas. (Source: NYT Health)
Source: NYT Health - September 28, 2018 Category: Consumer Health News Authors: DANIEL VICTOR and TIFFANY MAY Tags: Hepatitis Tests (Medical) Rats University of Hong Kong Source Type: news

World's first human case of ‘rat disease’ found in a 56-year-old man in Hong Kong
The unnamed man, who caught hepatitis E from a rat, lives in the Choi Wan housing estate in Hong Kong, and researchers said there were signs of rat infestation near his home. (Source: the Mail online | Health)
Source: the Mail online | Health - September 28, 2018 Category: Consumer Health News Source Type: news

World's first human case of rat disease discovered
For the first time, a case of rat hepatitis E has been discovered in a human in Hong Kong. (Source: CNN.com - Health)
Source: CNN.com - Health - September 28, 2018 Category: Consumer Health News Source Type: news

Tolerability of DAAs for Hepatitis C in Older Adult Tolerability of DAAs for Hepatitis C in Older Adult
Are direct-acting antiviral agents for treatment of HCV safe and effective for use in patients over 65?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 27, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Coping with side effects of hepatitis C drugs
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - September 27, 2018 Category: Consumer Health News Source Type: news

Gilead launches generic versions of hepatitis C drugs
These generic versions of its hepatitis C drugs will be launched through newly created subsidiary Asegua Therapeutics (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 25, 2018 Category: Pharmaceuticals Source Type: news

Feasibility and Cost-effectiveness of Reaching WHO HCV Targets Feasibility and Cost-effectiveness of Reaching WHO HCV Targets
This study evaluated the success and cost-effectiveness of initiatives to increase HCV treatment uptake and interventions for reducing the incidence of new infection among injection drug users.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 25, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Gilead to launch generic versions of its hepatitis drugs
Gilead Sciences Inc said on Monday it plans to launch generic versions of its hepatitis C drugs in the United States, at a time when regulators are looking to lower healthcare costs. (Source: Reuters: Health)
Source: Reuters: Health - September 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Brazil court strips Gilead of hepatitis C drug patent
A Brazilian court has stripped the patent protection of a Gilead Sciences Inc big-selling hepatitis C treatment in Brazil at the behest of a presidential candidate who pushed for the move, paving the way for cheaper generics. (Source: Reuters: Health)
Source: Reuters: Health - September 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Hepatitis A Outbreak Reported Among At-Risk Populations In Mass.; 1 Dead
BOSTON (CBS) – The Massachusetts Department of Public Health is reporting an increase in hepatitis A cases in the state. The department says there have been 65 total cases reported statewide since April, including 30 in Boston. The infected patients had been experiencing homelessness or substance use disorder, according to the department. One infected person has died. We are working with local health departments and providers to increase services and vaccination for an outbreak of #hepatitis A infection in people experiencing #homelessness and/or #substanceuse disorder. Read the press release: https://t.co/TcVMC96V...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 24, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Hepatitis A Local TV Source Type: news

Brazil court strips Gilead hepatitis drug patent, politician says
A Brazilian court has stripped the patent protection of a Gilead Sciences Inc big-selling hepatitis C treatment in Brazil, paving the way for cheaper generics, a presidential candidate who pushed for the move said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - September 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: What to know about the anti-smooth muscle antibody test
When a person has a liver condition, their body produces high levels of anti-smooth muscle antibodies (ASMA). Doctors check for these antibodies using the ASMA blood test. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 21, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

'I gave birth, and got Hepatitis C'
When Jackie Britton was given a blood transfusion during childbirth, it could have killed her. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 21, 2018 Category: Consumer Health News Source Type: news

Advice for Treating Infectious Diseases in Patients Affected by Hurricane Florence
The Centers for Disease Control and Prevention (CDC) is working with federal, state, territorial, and local agencies in response to recent hurricanes. Clinicians assessing patients affected by Hurricane Florence should be vigilant in looking for certain infectious diseases, including leptospirosis, hepatitis A, vibriosis, and influenza. Background Hurricane Florence made landfall in Wrightsville Beach, North Carolina, on September 14 causing widespread flooding. Natural hazards associated with the storms continue to affect many areas. Infectious disease outbreaks of diarrheal and respiratory illnesses c...
Source: JEMS Patient Care - September 20, 2018 Category: Emergency Medicine Authors: Centers for Disease Control and Prevention (CDC) Tags: Patient Care News Source Type: news

Advice for Treating Infectious Diseases in Patients Affected by Hurricane Florence
The Centers for Disease Control and Prevention (CDC) is working with federal, state, territorial, and local agencies in response to recent hurricanes. Clinicians assessing patients affected by Hurricane Florence should be vigilant in looking for certain infectious diseases, including leptospirosis, hepatitis A, vibriosis, and influenza. Background Hurricane Florence made landfall in Wrightsville Beach, North Carolina, on September 14 causing widespread flooding. Natural hazards associated with the storms continue to affect many areas. Infectious disease outbreaks of diarrheal and respiratory illnesses c...
Source: JEMS: Journal of Emergency Medical Services News - September 20, 2018 Category: Emergency Medicine Authors: Centers for Disease Control and Prevention (CDC) Tags: Patient Care News Source Type: news

Overwhelming evidence shows hepatitis C treatment effective for people who inject drugs
(University of New South Wales) Researchers are calling on an end to discriminatory health and illicit drugs policies, based on overwhelming evidence that new hepatitis C therapies are effective at curing the virus in people who inject drugs. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 20, 2018 Category: Infectious Diseases Source Type: news

Woman, 71, develops hepatitis after taking turmeric supplements to prevent a stroke
The unnamed 71-year-old, believed to be from Arizona, suffered no symptoms but was referred to a specialist when a check-up found she had abnormally high enzyme levels in her liver. (Source: the Mail online | Health)
Source: the Mail online | Health - September 18, 2018 Category: Consumer Health News Source Type: news

A Pathway to Support GPs to Prescribe DAA Therapy for HCV A Pathway to Support GPs to Prescribe DAA Therapy for HCV
This study describes an Australian program which enables general practitioners, via consultation with a specialist, to prescribe direct-acting antivirals to treat HCV.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 18, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

NUS researchers invent new test kit for quick, accurate and low-cost screening of diseases
(National University of Singapore) A multidisciplinary team of researchers at the National University of Singapore (NUS) has developed a portable, easy-to-use device for quick and accurate screening of diseases. This versatile technology platform called enVision (enzyme-assisted nanocomplexes for visual identification of nucleic acids) can be designed to detect a wide range of diseases - from emerging infectious diseases (e.g. Zika and Ebola) and high-prevalence infections (e.g. hepatitis, dengue, and malaria) to various types of cancers and genetic diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 18, 2018 Category: Cancer & Oncology Source Type: news

Improving HCV Care through Telementoring with Project ECHO
Scroll through our quick slideshow to see how 3 recently published studies highlight the need for a telementoring program in HCV care. (Source: ConsultantLive)
Source: ConsultantLive - September 17, 2018 Category: Internal Medicine Authors: Andrew Bowser Tags: Hepatitis C Source Type: news

Patrons of'Vampire Facial' Spa May Have Been Exposed to HIV
FRIDAY, Sept. 14, 2018 -- Customers of an Albuquerque spa who received a " vampire facial " are being warned that they may have been exposed to HIV, hepatitis B and hepatitis C through human blood used in the controversial procedure. In a vampire... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2018 Category: Pharmaceuticals Source Type: news

Gilead taps Durham gene editing firm for $445M deal
California biotech Gilead Sciences (Nasdaq: GILD) has teamed up with a Durham-based Precision BioSciences to develop therapies targeting hepatitis B – a deal that could be worth $445 million. At the center of the deal is Durham-based Precision BioSciences’ genome editing platform, dubbed ARCUS. On an earnings call, John McHutchison, Gilead’s chief scientific officer and head of research and development (and former Associate Director of t he Duke Clinical Research Institute in Durham), said… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 14, 2018 Category: Biotechnology Authors: Lauren K. Ohnesorge Source Type: news

New book on Enteric Hepatitis Viruses from Cold Spring Harbor Laboratory Press
(Cold Spring Harbor Laboratory Press) 'Enteric Hepatitis Viruses', published by CSHLPress, examines recent progress in our understanding of the biology and pathogenic mechanisms of HAV and HEV, as well as prospects for improving their control. Contributors explore the molecular characteristics and life cycles of HAV and HEV, their interactions with the liver and immune system, the clinical manifestations of the infections they cause, and their transmission via contaminated food and water. Additional topics include the geographic distributions of the various HAV and HEV genotypes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 14, 2018 Category: Infectious Diseases Source Type: news

HCV Interview with Sanjeev Arora, MD, Project ECHO Founder
How to expand HCV care through primary care networks is a passion for Dr Arora, a prominent HCV specialist and founder of Project ECHO (Extension for Community Healthcare Outcomes). (Source: ConsultantLive)
Source: ConsultantLive - September 13, 2018 Category: Internal Medicine Authors: Andrew Bowser Tags: Hepatitis C Source Type: news

Gilead taps Durham gene editing firm for $445M deal
California biotech Gilead Sciences (Nasdaq: GILD) has teamed up with a Durham-based Precision BioSciences to develop therapies targeting hepatitis B – a deal that could be worth $445 million. At the center of the deal is Durham-based Precision BioSciences’ genome editing platform, dubbed ARCUS. On an earnings call, John McHutchison, Gilead’s Chief Scientific Officer and head of research and development (and former Associate Director of t he Duke Clinical Research Institute in Durham), said… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 13, 2018 Category: American Health Authors: Lauren K. Ohnesorge Source Type: news

Hep C 5-Question Quiz: What Would WHO Do?
HCV testing in HIV-infected men who have sex with men should be conducted every 2 years. True or False? (Source: ConsultantLive)
Source: ConsultantLive - September 13, 2018 Category: Internal Medicine Authors: Andrew Bowser Tags: Hepatitis C Source Type: news